Page 110 - 《中国药房》2024年8期
P. 110
推荐剂量为 15 mg,qd。本案例的体重为 44 kg,肝肾功 crophorum(Necrobacillosis),with a focus on Lemierre’s
能均正常,故予利伐沙班片 15 mg,qd,出院后继续口服 syndrome[J]. Clin Microbiol Rev,2007,20(4):622-659.
至足疗程(4 周)。临床药师对患者进行用药教育,嘱使 [10] VIJAY V,FATTAH Z. Lesson of the month 1:Lemierre’s
用抗菌药物期间禁止饮用含有酒精的饮料,密切观察有 syndrome:a reminder of the “forgotten disease”[J]. Clin
Med,2018,18(1):100-102.
无黑便、皮下瘀斑、牙龈出血等情况。2 个月后,复查结
[11] DASARI S P,JHA P. A systematic review of Lemierre’s
果示患者恢复良好,超声检测示双侧颈部大血管旁无明
syndrome with a focus on ophthalmologic complications
显异常,无出血等其他不适。
[J]. Cureus,2020,12(7):e9326.
4 结语 [12] CHAKER K,BERRADA O,LYOUBI M,et al. Lemierre’s
LS是一种罕见疾病,好发于青少年人群。临床医务 syndrome or re-emerging disease:case report and litera‐
人员应提高对LS诊断及治疗的认识。在本案例的治疗 ture review[J]. Int J Surg Case Rep,2021,78:151-154.
过程中,临床先进行了细菌培养,但未得到明确的病原 [13] ITO I,KADOWAKI S,TANABE N,et al. Tazobactam/
学结果;然后,通过血mNGS技术确定了致病菌,同时结 piperacillin for moderate-to-severe pneumonia in patients
合影像学确认血栓形成,明确诊断为LS。目前,LS治疗 with risk for aspiration:comparison with imipenem/cilas‐
tatin[J]. Pulm Pharmacol Ther,2010,23(5):403-410.
尚无相关指南共识指导,治疗数据十分有限,临床药师
[14] PATEL P N,LEVI J R,COHEN M B. Lemierre’s syn‐
通过解读血 mNGS 检测结果,查阅大量循证医学证据,
drome in the pediatric population:trends in disease presen‐
运用药学专业特长,协助医师制定了 LS 患者的抗感染
tation and management in literature[J]. Int J Pediatr Oto‐
和抗凝治疗方案,为其个体化用药提供了依据,保障了 rhinolaryngol,2020,136:110213.
患者治疗的安全有效。 [15] CAMPO F,FUSCONI M,CIOTTI M,et al. Antibiotic
参考文献 and anticoagulation therapy in Lemierre’s syndrome:case
[ 1 ] KARKOS P D,ASRANI S,KARKOS C D,et al. report and review[J]. J Chemother,2019,31(1):42-48.
Lemierre’s syndrome:a systematic review[J]. Laryngo‐ [16] BONDY P,GRANT T. Lemierre’s syndrome:what are
scope,2009,119(8):1552-1559. the roles for anticoagulation and long-term antibiotic
[ 2 ] SACCO C,ZANE F,GRANZIERA S,et al. Lemierre syn‐ therapy? [J]. Ann Otol Rhinol Laryngol,2008,117(9):
drome:clinical update and protocol for a systematic re‐ 679-683.
view and individual patient data meta-analysis[J]. Hamo‐ [17] MONAGLE P,CUELLO C A,AUGUSTINE C,et al.
staseologie,2019,39(1):76-86. American Society of Hematology 2018 guidelines for
[ 3 ] HAGELSKJAER KRISTENSEN L,PRAG J. Lemierre’s management of venous thromboembolism:treatment of
syndrome and other disseminated Fusobacterium ne- pediatric venous thromboembolism[J]. Blood Adv,2018,2
crophorum infections in Denmark:a prospective epidemio‐ (22):3292-3316.
logical and clinical survey[J]. Eur J Clin Microbiol Infect [18] GE J,ZHOU P P,YANG Y F,et al. Anticoagulation may
Dis,2008,27(9):779-789. contribute to antimicrobial treatment of Lemierre syn‐
drome:a case report[J]. Thromb J,2021,19(1):80.
[ 4 ] LEE W S,JEAN S S,CHEN F L,et al. Lemierre’s syn‐
[19] PHAN T,SO T Y. Use of anticoagulation therapy for jugu‐
drome:a forgotten and re-emerging infection[J]. J Micro‐
lar vein thrombus in pediatric patients with Lemierre’s
biol Immunol Infect,2020,53(4):513-517.
syndrome[J]. Int J Clin Pharm,2012,34(6):818-821.
[ 5 ] 何慕芝,蔡闯,池丽庄,等. Lemierre综合征1例及文献复
[20] ADEDEJI A,CHUKWURA O,OBAFEMI T,et al. Anti‐
习[J]. 解放军医学杂志,2008,33(7):910-911.
coagulation strategies in the management of Lemierre syn‐
HE M Z,CAI C,CHI L Z,et al. Lemierre syndrome:a
drome:a systematic review of the literature[J]. Ann Phar‐
case report and literature review[J]. Med J Chin People’s
macother,2021,55(5):658-665.
Liberation Army,2008,33(7):910-911.
[21] BEAM D M,KAHLER Z P,KLINE J A. Immediate dis‐
[ 6 ] LE C,GENNARO D,MARSHALL D,et al. Lemierre’s
charge and home treatment with rivaroxaban of low-risk
syndrome:one rare disease-two case studies[J]. J Clin
venous thromboembolism diagnosed in two U. S. emer‐
Pharm Ther,2019,44(1):122-124.
gency departments:a one-year preplanned analysis[J].
[ 7 ] JOHANNESEN K M,BODTGER U. Lemierre’s syn‐
Acad Emerg Med,2015,22(7):788-795.
drome:current perspectives on diagnosis and management [22] LASSANDRO G,PALMIERI V V,PALLADINO V,et
[J]. Infect Drug Resist,2016,9:221-227. al. Venous thromboembolism in children:from diagnosis
[ 8 ] KUPPALLI K,LIVORSI D,TALATI N J,et al. Lemierre’s to management[J]. Int J Environ Res Public Health,2020,
syndrome due to Fusobacterium necrophorum[J]. Lancet 17(14):4993.
Infect Dis,2012,12(10):808-815. (收稿日期:2023-12-12 修回日期:2024-03-19)
[ 9 ] RIORDAN T. Human infection with Fusobacterium ne- (编辑:陈 宏)
· 1000 · China Pharmacy 2024 Vol. 35 No. 8 中国药房 2024年第35卷第8期